Please use this identifier to cite or link to this item:
http://nopr.niscpr.res.in/handle/123456789/5620| Title: | Preclinical studies for gene therapy of head and neck cancers using the HSV-tk/GCV strategy |
| Authors: | Wagle, Archana S Joshi, Ganesh V Naresh, Kikkeri N Mulherkar, Rita |
| Keywords: | gene therapy;HSV-tk;xenograft;nude mice;ganciclovir;head and neck cancer |
| Issue Date: | Jan-2005 |
| Publisher: | CSIR |
| IPC Code: | Int. Cl.7 C 12 N 5/16, 15/12, 15/28 |
| Abstract: | The present study has used the suicide gene Herpes Simplex Virus–thymidine kinase (HSV-tk) and ganciclovir (GCV) strategy. A 2 kb sequence of HSV-tk was subcloned into the retroviral vector resulting in a recombinant vector, LTKSN, which was transfected into a packaging cell-line, PA317 and selected on G418. The highest expressing clone, PTK-16 was used for in vitro experiments. Intra-tumoural injections of PTK-16 followed by GCV treatment, in a HNSCC xenograft model in nude mice, showed a significant reduction in the viable tumour volume (p=0.009). These results will form the basis for future clinical trials in HNSCC. |
| Page(s): | 82-87 |
| ISSN: | 0975-0967 (Online); 0972-5849 (Print) |
| Appears in Collections: | IJBT Vol.04(1) [January 2005] |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| IJBT 4(1) 82-87.pdf | 199.72 kB | Adobe PDF | View/Open |
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.